NCT04118036

Abemaciclib + Pembrolizumab In Glioblastoma

Public trial-level signal summary for this oncology Phase 2 record.

Record overview

Status and phase

Status: WITHDRAWN

Phase: PHASE2

Sponsor: Dana-Farber Cancer Institute

Condition: Glioblastoma

Signal summary

Status signal: Registry Stop Signal

Timeline signals: None

Results signal: Low Signal

Operational burden: rare_population_signal | strict_eligibility_signal

Stopped reason

safety concerns